Journals / Göztepe Tıp Dergisi / 2005 / Cilt: 20 - Sayı: 4

Thyroid functions in rheumatismal diseases

Romatizmal hastalıklarda tiroid fonksiyonları

Pages
200–204
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With proper combined treatment we can get better results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thyroid hormones are one of the most effective hormones on musculoskeletal system.
📊
Key Findings & Data:We aimed to evaluate the effects of thyroid function diseases on the occurrance of rheumatological diseases and coincidency of these two entities.873 patients with rheumatological disorders were involved to the study. 1.01 % of patients with osteoarthritis had subclinical hypothyroidism, 3.03 % had subclinical hyperthyroidism, 1.77 % had clinical hyperthyroidism. 2.5 % of patients with osteoporosis had subclinical hypothyroidism, 11.95 % had subclinical hyperthyroidism, 2.17 % had clinical hyperthyroidism. 0.8 % of patients with soft tissue rheumatological diseases had subclinical hypothyroidism, 5.3 % had subclinical hyperthyroidism and 3.84 % of patiens with discus diseases had subclinical hyperthyroidism. 2.08 % of patients with fibromyalgia had subclinical hypothyroidism, 2.08 % of patients with fibromyalgia had subclinical hyperthyroidism. 11.76 % of patients with rheumatoid arthritis , 3.3 % of patients with ancylosing spondylitis, 7.6 % of patients with carpal-tunnel syndrome had subclinical hyperthyroidism.
💡
Conclusion & Impact:With proper combined treatment we can get better results.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Thyroid hormones are one of the most effective hormones on musculoskeletal system. It is well known that thyroid gland dysfunctions cause a variety of rheumatologic signs and symptoms including muscle weakness, fatigue and osteopenia. We aimed to evaluate the effects of thyroid function diseases on the occurrance of rheumatological diseases and coincidency of these two entities.873 patients with rheumatological disorders were involved to the study. 1.01 % of patients with osteoarthritis had subclinical hypothyroidism, 3.03 % had subclinical hyperthyroidism, 1.77 % had clinical hyperthyroidism. 2.5 % of patients with osteoporosis had subclinical hypothyroidism, 11.95 % had subclinical hyperthyroidism, 2.17 % had clinical hyperthyroidism. 0.8 % of patients with soft tissue rheumatological diseases had subclinical hypothyroidism, 5.3 % had subclinical hyperthyroidism and 3.84 % of patiens with discus diseases had subclinical hyperthyroidism. 2.08 % of patients with fibromyalgia had subclinical hypothyroidism, 2.08 % of patients with fibromyalgia had subclinical hyperthyroidism. 11.76 % of patients with rheumatoid arthritis , 3.3 % of patients with ancylosing spondylitis, 7.6 % of patients with carpal-tunnel syndrome had subclinical hyperthyroidism. Two patients with syctemic sclerosis and overlap syndrome had normal thyroid functions.As a result, a variety of rheumatological and thyroid pathologies may overlap and thyroid diseases should always be in mind when evaluating rheumatological diseases. With proper combined treatment we can get better results.

Özet

Kas iskelet sistemi üzerine etkili en önemli hormonlardan birisi tiroid hormonudur. Tiroid fonksiyon bozukluklarının kas güçsüzlüğü, yorgunluk, osteopeni gibi romotolojik semptom ve bulgulara neden olduğu bilinmektedir. Bu sebeple, romatizmal hastalıkların ortaya çıkmasına tiroid fonksiyon bozukluklarının ne oranda katkıda bulunduğunu ve birlikteliklerini araştırmak istedik.Çalışmaya tek bir romatizmal hastalığı olan 873 hasta alındı. Osteoartrit olgularının % 1.01'inde subklinik hipotiroidi, % 3.03'ünde subklinik hipertiroidi, % 1.77'sinde hipertiroidi vardı. Osteoporoz olgularının % 2.5'inde subklinik hipotiroidi, % 11.95'inde subklinik hipertiroidi, % 2.17'sinde hipertiroidi saptandı. Yumuşak doku romatizmalı olguların % 0.8'inde subklinik hipotiroidi, % 5.3'ünde subklinik hipertiroidi ve disk hastalığı olan olguların da % 3.84'ünde subklinik hipertiroidi bulundu. FM olgularının % 2.08'inde (1) subklinik hipotiroidi, % 2.08'inde (1) TSH seviyesinde düşüklük saptandı. RA olgularının % 11.76'sında (2) TSH düzeyinde düşüklük saptanırken, AS hastalarında bu oran % 3.3 (1), KTS hastalarda ise % 7.6 (1) olarak gözlendi. Sistemik skleroz ve çakışma sendromlu 2 hastanın tiroid fonksiyon testlerinde herhangi bir bozukluk saptanmadı.Sonuç olarak; romatolojik hastalıklarla tiroid patolojileri çakışabilileceğinden romatizmal şikayetlerin kökenine inildiğinde tiroid patolojileri göz ardı edilmemeli ve uygun tedaviyle klinik sonuçların çok daha iyi olabileceği unutulmamalıdır.

🔖

Cite This Article

YAZICI, S., YAĞLI, M., ATAOĞLU, S. (2022). Thyroid functions in rheumatismal diseases. Göztepe Tıp Dergisi, Cilt: 20 - Sayı: 4, 200–204. https://ajindex.com/articles/526456

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Duffy RF, Van den Bosch J, Laman DM: Neuromusculer fin¬ dings in thyroid dysfunction? a prospective clinical and electrodiag- nosticstudy. J Neurol Neurosurg Psychiatry 68:750-5, 2000
  2. Harper KD, Weber _TJ: Secondary Osteoporosis. Diagnostic, con- siderations. Endoc Met Clin North Am 27(2):325-48, 1998
  3. Erdoğan G: The survey for the endemic goiter etiology in Turkey; iodine content in Ankara, Kastamonu, Trabzon and Bayburt XXI. Turkish Endocrine Society Meeting SMP 1:25-7, 1998
  4. Göğüs Feride: Romatoid Artrit klinik ve laboratuar bulguları. Göksoy T, editör. Romatizmal Hastalıkların Tanı ve Tedavisi. Yüce Yayınları 2002, 436-48
  5. Şimşek E: Bolu ve Düzce illerinde endemik iyot eksikliğinin ço- cukların boy persantilleri üzerine etkisi. Çocuk Sağlığı ve Hastalıkları Dergisi 2002; 45 (baskıda)
  6. Boyages SC: Clinical review 49. Iodine deficiency disorders. J Clin E ndocrinol Metab 3:59-69, 1993
  7. Akyiiz G: Osteoartroz tanımı, sınıflandırması ve epidemiyolojisi. Gökçe-Kutsal Y, editör. Osteoartroz. Modern Tıp Seminerleri 7. Gü- neş Kitabevi 2000, 13-8
  8. Chaisson CE, McAIindon TE, Falson DT, Naimark A, Wilson PW, Sawin CT: Lack of association between thyroid status and chondrocalcinosis or osteoarthritis. The Framingham Osteoarthritis Study. J Rheumatol 23(4):711-5, 1996
  9. Uzzan B, Campos J, Cucherat M, Nony P, Boissel P, Perret GY: Effects on bone mass of long term treatment with thyroid hormo- nes: A meta analysis. J Clin Endocrinal Metab 81:4278-89, 1996
  10. Auwarx J, Bouiller R: Mineral and bune metabolism in thyroid disease: A Review. Querterly Journal of Medicine 232:737-52, 1986
  11. Lakatos P: Thyroid hormones: Beneficial or deleterious for bone? Calcif Tissue Int 2003 Oct 6 (Epub ahead of print)
  12. Glenn M, Harris S: Accelerated bone loss in hypothyroid p; ents overtreated with L-throxine. Annals of Internal Medici 113:265-69,1990
  13. Clauw DJ: Fibromiyalgia. In: Ruddy S, Harris Jr, Sledge CB, e tors. Kelley's Textbook of Rheumatology. 6th edition. WB Saund Company. Philedelphia 2001, 41
  14. Staub JJ, Althous BU, Engler H, Ryff AS, Teabucco P, MI guards K, et al: Spectrum of subclinical and overt hypothyroidis Effect on Thyrotropin, Prolactin and thyroid reserve, and metabc impact on peripheral target tissues. The American Journal of Medi ne 92:631-41, 1992
  15. Neeck G, Riedel W: Thyroid function in patients with fibromy gia syndrome. J Rheumatol 19:1120-2, 1992
  16. Caron P, Lassowed S, Prower C, Oksman F, Fournie A: Pre1 l